Ultrasound-Activated Particles as CRISPR/Cas9 Delivery System for Androgenic Alopecia Therapy

December 2019 in “ Biomaterials ”

Jee Hoon Ryu, Eun Jeong Won, Han Chu Lee, Jin-Soo Kim, Emmanuel Hui, Hojoong Kim, Tae-Jong Yoon

ultrasound-activated particles CRISPR/Cas9 androgenic alopecia SRD5A2 gene VEGF protein gene editing hair regeneration hair loss hair growth

TLDR Scientists have created a new hair loss treatment using ultrasound to deliver gene-editing particles, which resulted in up to 90% hair regrowth in mice.

In 2020, researchers developed a novel method for treating androgenic alopecia (hair loss) using ultrasound-activated particles to deliver the CRISPR/Cas9 gene-editing system. The particles were designed to target and edit the SRD5A2 gene, a major contributor to hair loss. The study involved 10 mice and the treatment led to a decrease in SRD5A2 mRNA and protein levels, and an increase in VEGF protein level, which stimulates hair growth. The results showed high efficiency in gene editing and up to 90% hair regeneration in the treated mice by the 7th week. However, further study was needed due to observed off-target effects of less than 3% each.

View this study on sciencedirect.com →

Discuss this study in the Community →

Research cited in this study

4 / 4 results

A Randomized, Active- and Placebo-Controlled Study of the Efficacy and Safety of Different Doses of Dutasteride Versus Placebo and Finasteride in the Treatment of Male Subjects with Androgenetic Alopecia

research A Randomized, Active- and Placebo-Controlled Study of the Efficacy and Safety of Different Doses of Dutasteride Versus Placebo and Finasteride in the Treatment of Male Subjects with Androgenetic Alopecia

97 citations, January 2014 in “Journal of The American Academy of Dermatology”

Dutasteride 0.5 mg works better than finasteride and placebo for increasing hair in men with hair loss.

research Hematological And Hepatic Effects Of Vascular Epidermal Growth Factor (VEGF) Used To Stimulate Hair Growth In An Animal Model

30 citations, October 2013 in “BMC dermatology”

VEGF gel increases hair growth but may have potential toxicity.

research Comparative Efficacy of Various Treatment Regimens for Androgenetic Alopecia in Men

80 citations, August 2002 in “Journal of Dermatology”

Best hair growth results from combining finasteride and minoxidil.

The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment Among Men with Benign Prostatic Hyperplasia

research The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment Among Men with Benign Prostatic Hyperplasia

1054 citations, February 1998 in “The New England Journal of Medicine”

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

Similar Research

5 / 1000+ results

research Stimuli-Responsive Nanoformulations for CRISPR-Cas9 Genome Editing

7 citations, August 2022 in “Journal of Nanobiotechnology”

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

research Potential Application of PBM in Hair Follicle Organoid Culture for the Treatment of Androgenic Alopecia

November 2023 in “Materials Today Bio”

Light therapy might help treat hereditary hair loss by improving hair follicle growth in lab cultures.

research CRISPR/Cas9: A Promising Approach for Alopecia

January 2024 in “Biomedical journal of scientific & technical research”

CRISPR/Cas9 gene-editing may effectively treat hair loss but requires more research for safe use.

research Nanomaterials in Hair Care and Treatment

5 citations, February 2022 in “Acta Biomaterialia”

Nanomaterials can improve hair care products and treatments, including hair loss and alopecia, by enhancing stability and safety, and allowing controlled release of compounds, but their safety in cosmetics needs more understanding.

research Non-Viral Delivery of the CRISPR/Cas System: DNA Versus RNA Versus RNP

21 citations, January 2022 in “Biomaterials Science”

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

Ultrasound-Activated Particles as CRISPR/Cas9 Delivery System for Androgenic Alopecia Therapy

Research cited in this study

research A Randomized, Active- and Placebo-Controlled Study of the Efficacy and Safety of Different Doses of Dutasteride Versus Placebo and Finasteride in the Treatment of Male Subjects with Androgenetic Alopecia

research Hematological And Hepatic Effects Of Vascular Epidermal Growth Factor (VEGF) Used To Stimulate Hair Growth In An Animal Model

research Comparative Efficacy of Various Treatment Regimens for Androgenetic Alopecia in Men

research The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment Among Men with Benign Prostatic Hyperplasia

Related Community Posts Join

community New and Interesting HairLoss Studies/Papers/Reviews

community Peptides that Stop Hair Loss? | In-depth Literature Review Video

community Female with hair loss - turns out it’s been thyroid cancer

community Soundwaves & Electricity Grows Hair? | Peptide Delivery Model.

community New topical Dutasteride from Moogene will have 20 times better scalp absorption than oral Dutasteride. And much lower system absorption.